Regeneron and Telix to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model ...
Telix and Regeneron to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing ...
Long termed as the ‘Pharmacy of the World’ due to its leadership in generic medicines, India’s pharma industry is now ready ...
Many people believe natural therapies are safer — but that’s not always true. Here’s what you need to know about risk, dosage ...
Mixed reactions yesterday trailed the Federal Government's approval of the new 2026 fiscal policy which reduced import tariffs on drugs and pharmaceutical products, cars and rice, among others.While ...
Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
The Government of Canada is taking action to streamline access to medicines to save lives, reduce costs, and build our economy.
Blindly following quick weight loss trends, or using flashy products risks overall health and skin integrity. This explains why weight loss measures should be holistic and sustainable in nature.
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of electronic health record data ...
Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results